Topic Archives: DocGumshoe

[Ed note: Following is another installment from our favorite medical scribe, “Doc Gumshoe” (no, he’s not a doctor). We feature Michael’s commentary every couple weeks or so, and his thoughts and words are his own. “Doc” doesn’t pick stocks, but FDA decisions are a huge driver of investment success for pharmaceutical and biotech companies and […]

Robert Morris is helming a biotech-focused stock newsletter that’s called Biotech Supertrader (modesty has no place in the world of newsletter promotions, of course), and I’ve never covered this letter before so I thought I ought to have a look at the latest teaser we’ve been asked about. Morris, incidentally, has been featured in our […]

[ed note: We feature the musings of our favorite health and medicine writer, Michael Jorrin, a couple times a month, and we’ve taken the liberty of calling him “Doc Gumshoe” (he’s not a doctor). You’ll find no stock picks in his pieces, but hopefully will get plenty of insight into the medical matters he explains […]

Today we’re sharing another piece from our medical contributor, “Doc Gumshoe” — we have added the stock tickers to the companies he mentions for your researching convenience, but this survey of the state of cancer research — which will hopefully be good background help to folks trying to understand the basic science behind pitches for […]

The one area of the web that has as many “self help” and “miracle solutions” newsletters (and marketing teasers) as personal finance is health — the investing newsletters promise eternal wealth, and the health newsletters promise eternal life (or something dang close). Readers ask us about the crazy marketing for these health newsletters all the […]

Comments

  • Avatar

    Will be interesting to see if Travis' recommendation of ATVI changes in light of their dropping a gamer over their banni...

  • Avatar

    i was wondering the same thing about the shadow training for this? I just purchased his options strategy proceeding the...

  • Avatar

    Interesting! Memory says that ATVI has been one of David Gardner's reco's & re-reco's over the years and I'm a bit s...

  • Avatar

    Wasn't Activision Blizzard hit with a class action suit last week for misleading investors about the status of their pa...

  • Avatar

    jamessko: I so echo your comments on limits and stops. I am truly confounded, especially when facing the horrible & co...

  • Travis Johnson, Stock Gumshoe

    Haven’t looked through the filing yet, but ATVI is on my list to follow up — thanks for the reminder....

  • Avatar

    Travis, in your last Friday File, you mentioned about Activision Blizzard (ATVI) being tempting. It is down ~13% today....

  • Avatar

    Every decade gives us our unique capabilities. Activision Blizzard developing particularly dynamically so put a bet on i...

  • Avatar

    Okay, since the cat's out of the bag, Dis was one of the three companies that had already been recently recommended when...

  • Avatar

    Improving cash from operations. Activision Blizzard is generally able to produce more consistent profits and cash flow t...

  • Avatar

    Do you mean Blizzard Entertainment (of World of Warcraft?) Investors have never been able to own them directly (at least...

  • Avatar

    You're abolutely right about Navellier. I subscribed to his Blue Chip Growth last year and sent them numerous emails ask...

  • Avatar

    Activision Blizzard may be a great pick. As an old school video game junky let me tell you that in the world of video g...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info